Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-31 ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D Grant or award · Employee stock option (right to buy) +65,000 65,000
2024-01-31 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Grant or award +25,000 81,034
2024-01-31 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Grant or award · Employee stock option (right to buy) +65,000 65,000
2024-01-31 Heerma Peter CHIEF COMMERCIAL OFFICER Grant or award +25,000 103,698
2024-01-31 Heerma Peter CHIEF COMMERCIAL OFFICER Grant or award · Employee stock option (right to buy) +65,000 65,000
2024-01-31 Inrig Jula CHIEF MEDICAL OFFICER Grant or award +25,000 60,248
2024-01-31 Inrig Jula CHIEF MEDICAL OFFICER Grant or award · Employee stock option (right to buy) +91,000 91,000
2024-01-31 Cline Christopher R. CHIEF FINANCIAL OFFICER Grant or award +25,000 74,721
2024-01-31 Cline Christopher R. CHIEF FINANCIAL OFFICER Grant or award · Employee stock option (right to buy) +65,000 65,000
2024-01-31 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Grant or award +12,500 53,837
2024-01-31 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Grant or award +1,000 54,837
2024-01-31 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Grant or award · Employee stock option (right to buy) +25,000 25,000
2024-01-23 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Sale −2,062 $8.96 $18K 56,034
2024-01-23 ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D Sale −2,062 $8.96 $18K 60,484
2024-01-23 Dube Eric M CHIEF EXECUTIVE OFFICER Sale −7,873 $8.96 $71K 234,722
2024-01-23 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale −853 $9.07 $8K 49,721
2024-01-23 Heerma Peter CHIEF COMMERCIAL OFFICER Sale −1,559 $9.07 $14K 78,698
2024-01-23 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale −910 $9.07 $8K 41,337
2024-01-04 Inrig Jula Chief Medical Officer Sale −440 $9.17 $4K 35,248
2024-01-03 Inrig Jula Chief Medical Officer Sale −2,069 $9.48 $20K 35,688

Page 25 of 51 · 1,020 trades